The study of cancer susceptibility syndromes like Fanconi Anemia and the BRCA1- and BRCA2-defective breast and ovarian cancer syndromes provided the first evidence for a causal link between defects causing increased genome rearrangements and the development of cancer4, 5. This evidence concerns the gene BRCA1 and cancer.